Global Hematology Oncology Diagnostics Production, Demand and Key Producers, 2022-2028
Physicians use a variety of tests to accurately diagnose cancer, determine prognosis, and monitor cancer for progression and side effects.
This report studies the global Hematology Oncology Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hematology Oncology Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hematology Oncology Diagnostics that contribute to its increasing demand across many markets.
The global Hematology Oncology Diagnostics market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Hematology Oncology Diagnostics total market, 2017-2028, (USD Million)
Global Hematology Oncology Diagnostics total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Hematology Oncology Diagnostics total market, key domestic companies and share, (USD Million)
Global Hematology Oncology Diagnostics revenue by player and market share 2017-2022, (USD Million)
Global Hematology Oncology Diagnostics total market by Type, CAGR, 2017-2028, (USD Million)
Global Hematology Oncology Diagnostics total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Hematology Oncology Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Roche, QIAGEN, Thermo Fisher Scientific, Illumina, Bio-Rad, ArcherDX, ARUP Laboratories and Asuragen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hematology Oncology Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Hematology Oncology Diagnostics Market, By Region:
1. How big is the global Hematology Oncology Diagnostics market?
2. What is the demand of the global Hematology Oncology Diagnostics market?
3. What is the year over year growth of the global Hematology Oncology Diagnostics market?
4. What is the total value of the global Hematology Oncology Diagnostics market?
5. Who are the major players in the global Hematology Oncology Diagnostics market?
6. What are the growth factors driving the market demand?
This report studies the global Hematology Oncology Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hematology Oncology Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hematology Oncology Diagnostics that contribute to its increasing demand across many markets.
The global Hematology Oncology Diagnostics market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Hematology Oncology Diagnostics total market, 2017-2028, (USD Million)
Global Hematology Oncology Diagnostics total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Hematology Oncology Diagnostics total market, key domestic companies and share, (USD Million)
Global Hematology Oncology Diagnostics revenue by player and market share 2017-2022, (USD Million)
Global Hematology Oncology Diagnostics total market by Type, CAGR, 2017-2028, (USD Million)
Global Hematology Oncology Diagnostics total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Hematology Oncology Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Roche, QIAGEN, Thermo Fisher Scientific, Illumina, Bio-Rad, ArcherDX, ARUP Laboratories and Asuragen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hematology Oncology Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Hematology Oncology Diagnostics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- PCR
- IHC
- NGS
- Cytogenetics
- Others
- Clinical Laboratories
- Hospitals
- Research Institutes
- Other
- Abbott Laboratories
- Roche
- QIAGEN
- Thermo Fisher Scientific
- Illumina
- Bio-Rad
- ArcherDX
- ARUP Laboratories
- Asuragen
- Invivoscribe
- Adaptive Biotechnologies
- Amoy Diagnostics
- ELITechGroup
- Vela Diagnostics
- Gentronix
- BioIVT
- SAGA Diagnostics
- Berry Genomics
1. How big is the global Hematology Oncology Diagnostics market?
2. What is the demand of the global Hematology Oncology Diagnostics market?
3. What is the year over year growth of the global Hematology Oncology Diagnostics market?
4. What is the total value of the global Hematology Oncology Diagnostics market?
5. Who are the major players in the global Hematology Oncology Diagnostics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Hematology Oncology Diagnostics Introduction
1.2 World Hematology Oncology Diagnostics Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Hematology Oncology Diagnostics Total Market by Region
1.3.1 World Hematology Oncology Diagnostics Market Size by Region (2017-2028)
1.3.2 United States Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.3 China Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.4 Europe Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.5 Japan Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.6 South Korea Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.7 ASEAN Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.8 India Hematology Oncology Diagnostics Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hematology Oncology Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hematology Oncology Diagnostics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD HEMATOLOGY ONCOLOGY DIAGNOSTICS COMPANIES COMPETITIVE ANALYSIS
2.1 World Hematology Oncology Diagnostics Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Hematology Oncology Diagnostics Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Hematology Oncology Diagnostics in 2021
2.2.3 Global Concentration Ratios (CR8) for Hematology Oncology Diagnostics in 2021
2.3 Hematology Oncology Diagnostics Company Evaluation Quadrant
2.4 Hematology Oncology Diagnostics Market: Overall Company Footprint Analysis
2.4.1 Hematology Oncology Diagnostics Market: Region Footprint
2.4.2 Hematology Oncology Diagnostics Market: Company Product Type Footprint
2.4.3 Hematology Oncology Diagnostics Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Hematology Oncology Diagnostics Market Comparison
3.1.1 United States VS China: Hematology Oncology Diagnostics Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Hematology Oncology Diagnostics Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Hematology Oncology Diagnostics Major Players and Market Share, 2017-2022
3.2.1 Major Players of Hematology Oncology Diagnostics in United States, Headquarters (States, Country)
3.2.2 United States Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022)
3.3 China Hematology Oncology Diagnostics Major Players and Market Share, 2017-2022
3.3.1 Major Players of Hematology Oncology Diagnostics in China, Headquarters (Province, Country)
3.3.2 China Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Hematology Oncology Diagnostics Major Players and Market Share, 2017-2022
3.4.1 Major Players of Hematology Oncology Diagnostics in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Hematology Oncology Diagnostics Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 PCR
4.2.2 IHC
4.2.3 NGS
4.2.4 Cytogenetics
4.2.5 Others
4.3 Market Segment by Type
4.3.1 World Hematology Oncology Diagnostics Market Size by Type (2017-2022)
4.3.2 World Hematology Oncology Diagnostics Market Size by Type (2023-2028)
4.3.3 World Hematology Oncology Diagnostics Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Hematology Oncology Diagnostics Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Clinical Laboratories
5.2.2 Hospitals
5.2.3 Research Institutes
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World Hematology Oncology Diagnostics Market Size by Application (2017-2022)
5.3.2 World Hematology Oncology Diagnostics Market Size by Application (2023-2028)
5.3.3 World Hematology Oncology Diagnostics Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Details
6.1.2 Abbott Laboratories Major Business
6.1.3 Abbott Laboratories Hematology Oncology Diagnostics Product and Services
6.1.4 Abbott Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Laboratories Recent Developments/Updates
6.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
6.2 Roche
6.2.1 Roche Details
6.2.2 Roche Major Business
6.2.3 Roche Hematology Oncology Diagnostics Product and Services
6.2.4 Roche Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Roche Recent Developments/Updates
6.2.6 Roche Competitive Strengths & Weaknesses
6.3 QIAGEN
6.3.1 QIAGEN Details
6.3.2 QIAGEN Major Business
6.3.3 QIAGEN Hematology Oncology Diagnostics Product and Services
6.3.4 QIAGEN Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 QIAGEN Recent Developments/Updates
6.3.6 QIAGEN Competitive Strengths & Weaknesses
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Details
6.4.2 Thermo Fisher Scientific Major Business
6.4.3 Thermo Fisher Scientific Hematology Oncology Diagnostics Product and Services
6.4.4 Thermo Fisher Scientific Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
6.5 Illumina
6.5.1 Illumina Details
6.5.2 Illumina Major Business
6.5.3 Illumina Hematology Oncology Diagnostics Product and Services
6.5.4 Illumina Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Illumina Recent Developments/Updates
6.5.6 Illumina Competitive Strengths & Weaknesses
6.6 Bio-Rad
6.6.1 Bio-Rad Details
6.6.2 Bio-Rad Major Business
6.6.3 Bio-Rad Hematology Oncology Diagnostics Product and Services
6.6.4 Bio-Rad Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Bio-Rad Recent Developments/Updates
6.6.6 Bio-Rad Competitive Strengths & Weaknesses
6.7 ArcherDX
6.7.1 ArcherDX Details
6.7.2 ArcherDX Major Business
6.7.3 ArcherDX Hematology Oncology Diagnostics Product and Services
6.7.4 ArcherDX Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 ArcherDX Recent Developments/Updates
6.7.6 ArcherDX Competitive Strengths & Weaknesses
6.8 ARUP Laboratories
6.8.1 ARUP Laboratories Details
6.8.2 ARUP Laboratories Major Business
6.8.3 ARUP Laboratories Hematology Oncology Diagnostics Product and Services
6.8.4 ARUP Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 ARUP Laboratories Recent Developments/Updates
6.8.6 ARUP Laboratories Competitive Strengths & Weaknesses
6.9 Asuragen
6.9.1 Asuragen Details
6.9.2 Asuragen Major Business
6.9.3 Asuragen Hematology Oncology Diagnostics Product and Services
6.9.4 Asuragen Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Asuragen Recent Developments/Updates
6.9.6 Asuragen Competitive Strengths & Weaknesses
6.10 Invivoscribe
6.10.1 Invivoscribe Details
6.10.2 Invivoscribe Major Business
6.10.3 Invivoscribe Hematology Oncology Diagnostics Product and Services
6.10.4 Invivoscribe Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Invivoscribe Recent Developments/Updates
6.10.6 Invivoscribe Competitive Strengths & Weaknesses
6.11 Adaptive Biotechnologies
6.11.1 Adaptive Biotechnologies Details
6.11.2 Adaptive Biotechnologies Major Business
6.11.3 Adaptive Biotechnologies Hematology Oncology Diagnostics Product and Services
6.11.4 Adaptive Biotechnologies Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Adaptive Biotechnologies Recent Developments/Updates
6.11.6 Adaptive Biotechnologies Competitive Strengths & Weaknesses
6.12 Amoy Diagnostics
6.12.1 Amoy Diagnostics Details
6.12.2 Amoy Diagnostics Major Business
6.12.3 Amoy Diagnostics Hematology Oncology Diagnostics Product and Services
6.12.4 Amoy Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Amoy Diagnostics Recent Developments/Updates
6.12.6 Amoy Diagnostics Competitive Strengths & Weaknesses
6.13 ELITechGroup
6.13.1 ELITechGroup Details
6.13.2 ELITechGroup Major Business
6.13.3 ELITechGroup Hematology Oncology Diagnostics Product and Services
6.13.4 ELITechGroup Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 ELITechGroup Recent Developments/Updates
6.13.6 ELITechGroup Competitive Strengths & Weaknesses
6.14 Vela Diagnostics
6.14.1 Vela Diagnostics Details
6.14.2 Vela Diagnostics Major Business
6.14.3 Vela Diagnostics Hematology Oncology Diagnostics Product and Services
6.14.4 Vela Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Vela Diagnostics Recent Developments/Updates
6.14.6 Vela Diagnostics Competitive Strengths & Weaknesses
6.15 Gentronix
6.15.1 Gentronix Details
6.15.2 Gentronix Major Business
6.15.3 Gentronix Hematology Oncology Diagnostics Product and Services
6.15.4 Gentronix Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Gentronix Recent Developments/Updates
6.15.6 Gentronix Competitive Strengths & Weaknesses
6.16 BioIVT
6.16.1 BioIVT Details
6.16.2 BioIVT Major Business
6.16.3 BioIVT Hematology Oncology Diagnostics Product and Services
6.16.4 BioIVT Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 BioIVT Recent Developments/Updates
6.16.6 BioIVT Competitive Strengths & Weaknesses
6.17 SAGA Diagnostics
6.17.1 SAGA Diagnostics Details
6.17.2 SAGA Diagnostics Major Business
6.17.3 SAGA Diagnostics Hematology Oncology Diagnostics Product and Services
6.17.4 SAGA Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 SAGA Diagnostics Recent Developments/Updates
6.17.6 SAGA Diagnostics Competitive Strengths & Weaknesses
6.18 Berry Genomics
6.18.1 Berry Genomics Details
6.18.2 Berry Genomics Major Business
6.18.3 Berry Genomics Hematology Oncology Diagnostics Product and Services
6.18.4 Berry Genomics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Berry Genomics Recent Developments/Updates
6.18.6 Berry Genomics Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Hematology Oncology Diagnostics and Key Manufacturers
7.2 Hematology Oncology Diagnostics Manufacturing Costs
7.3 Hematology Oncology Diagnostics Production Process
7.4 Hematology Oncology Diagnostics Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Hematology Oncology Diagnostics Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Hematology Oncology Diagnostics Typical Distributors
8.3 Hematology Oncology Diagnostics Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Hematology Oncology Diagnostics Introduction
1.2 World Hematology Oncology Diagnostics Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Hematology Oncology Diagnostics Total Market by Region
1.3.1 World Hematology Oncology Diagnostics Market Size by Region (2017-2028)
1.3.2 United States Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.3 China Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.4 Europe Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.5 Japan Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.6 South Korea Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.7 ASEAN Hematology Oncology Diagnostics Market Size (2017-2028)
1.3.8 India Hematology Oncology Diagnostics Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hematology Oncology Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hematology Oncology Diagnostics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD HEMATOLOGY ONCOLOGY DIAGNOSTICS COMPANIES COMPETITIVE ANALYSIS
2.1 World Hematology Oncology Diagnostics Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Hematology Oncology Diagnostics Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Hematology Oncology Diagnostics in 2021
2.2.3 Global Concentration Ratios (CR8) for Hematology Oncology Diagnostics in 2021
2.3 Hematology Oncology Diagnostics Company Evaluation Quadrant
2.4 Hematology Oncology Diagnostics Market: Overall Company Footprint Analysis
2.4.1 Hematology Oncology Diagnostics Market: Region Footprint
2.4.2 Hematology Oncology Diagnostics Market: Company Product Type Footprint
2.4.3 Hematology Oncology Diagnostics Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Hematology Oncology Diagnostics Market Comparison
3.1.1 United States VS China: Hematology Oncology Diagnostics Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Hematology Oncology Diagnostics Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Hematology Oncology Diagnostics Major Players and Market Share, 2017-2022
3.2.1 Major Players of Hematology Oncology Diagnostics in United States, Headquarters (States, Country)
3.2.2 United States Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022)
3.3 China Hematology Oncology Diagnostics Major Players and Market Share, 2017-2022
3.3.1 Major Players of Hematology Oncology Diagnostics in China, Headquarters (Province, Country)
3.3.2 China Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Hematology Oncology Diagnostics Major Players and Market Share, 2017-2022
3.4.1 Major Players of Hematology Oncology Diagnostics in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Hematology Oncology Diagnostics Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 PCR
4.2.2 IHC
4.2.3 NGS
4.2.4 Cytogenetics
4.2.5 Others
4.3 Market Segment by Type
4.3.1 World Hematology Oncology Diagnostics Market Size by Type (2017-2022)
4.3.2 World Hematology Oncology Diagnostics Market Size by Type (2023-2028)
4.3.3 World Hematology Oncology Diagnostics Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Hematology Oncology Diagnostics Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Clinical Laboratories
5.2.2 Hospitals
5.2.3 Research Institutes
5.2.4 Other
5.2.5 Other
5.3 Market Segment by Application
5.3.1 World Hematology Oncology Diagnostics Market Size by Application (2017-2022)
5.3.2 World Hematology Oncology Diagnostics Market Size by Application (2023-2028)
5.3.3 World Hematology Oncology Diagnostics Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Details
6.1.2 Abbott Laboratories Major Business
6.1.3 Abbott Laboratories Hematology Oncology Diagnostics Product and Services
6.1.4 Abbott Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Laboratories Recent Developments/Updates
6.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
6.2 Roche
6.2.1 Roche Details
6.2.2 Roche Major Business
6.2.3 Roche Hematology Oncology Diagnostics Product and Services
6.2.4 Roche Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Roche Recent Developments/Updates
6.2.6 Roche Competitive Strengths & Weaknesses
6.3 QIAGEN
6.3.1 QIAGEN Details
6.3.2 QIAGEN Major Business
6.3.3 QIAGEN Hematology Oncology Diagnostics Product and Services
6.3.4 QIAGEN Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 QIAGEN Recent Developments/Updates
6.3.6 QIAGEN Competitive Strengths & Weaknesses
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Details
6.4.2 Thermo Fisher Scientific Major Business
6.4.3 Thermo Fisher Scientific Hematology Oncology Diagnostics Product and Services
6.4.4 Thermo Fisher Scientific Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
6.5 Illumina
6.5.1 Illumina Details
6.5.2 Illumina Major Business
6.5.3 Illumina Hematology Oncology Diagnostics Product and Services
6.5.4 Illumina Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Illumina Recent Developments/Updates
6.5.6 Illumina Competitive Strengths & Weaknesses
6.6 Bio-Rad
6.6.1 Bio-Rad Details
6.6.2 Bio-Rad Major Business
6.6.3 Bio-Rad Hematology Oncology Diagnostics Product and Services
6.6.4 Bio-Rad Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Bio-Rad Recent Developments/Updates
6.6.6 Bio-Rad Competitive Strengths & Weaknesses
6.7 ArcherDX
6.7.1 ArcherDX Details
6.7.2 ArcherDX Major Business
6.7.3 ArcherDX Hematology Oncology Diagnostics Product and Services
6.7.4 ArcherDX Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 ArcherDX Recent Developments/Updates
6.7.6 ArcherDX Competitive Strengths & Weaknesses
6.8 ARUP Laboratories
6.8.1 ARUP Laboratories Details
6.8.2 ARUP Laboratories Major Business
6.8.3 ARUP Laboratories Hematology Oncology Diagnostics Product and Services
6.8.4 ARUP Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 ARUP Laboratories Recent Developments/Updates
6.8.6 ARUP Laboratories Competitive Strengths & Weaknesses
6.9 Asuragen
6.9.1 Asuragen Details
6.9.2 Asuragen Major Business
6.9.3 Asuragen Hematology Oncology Diagnostics Product and Services
6.9.4 Asuragen Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Asuragen Recent Developments/Updates
6.9.6 Asuragen Competitive Strengths & Weaknesses
6.10 Invivoscribe
6.10.1 Invivoscribe Details
6.10.2 Invivoscribe Major Business
6.10.3 Invivoscribe Hematology Oncology Diagnostics Product and Services
6.10.4 Invivoscribe Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Invivoscribe Recent Developments/Updates
6.10.6 Invivoscribe Competitive Strengths & Weaknesses
6.11 Adaptive Biotechnologies
6.11.1 Adaptive Biotechnologies Details
6.11.2 Adaptive Biotechnologies Major Business
6.11.3 Adaptive Biotechnologies Hematology Oncology Diagnostics Product and Services
6.11.4 Adaptive Biotechnologies Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Adaptive Biotechnologies Recent Developments/Updates
6.11.6 Adaptive Biotechnologies Competitive Strengths & Weaknesses
6.12 Amoy Diagnostics
6.12.1 Amoy Diagnostics Details
6.12.2 Amoy Diagnostics Major Business
6.12.3 Amoy Diagnostics Hematology Oncology Diagnostics Product and Services
6.12.4 Amoy Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Amoy Diagnostics Recent Developments/Updates
6.12.6 Amoy Diagnostics Competitive Strengths & Weaknesses
6.13 ELITechGroup
6.13.1 ELITechGroup Details
6.13.2 ELITechGroup Major Business
6.13.3 ELITechGroup Hematology Oncology Diagnostics Product and Services
6.13.4 ELITechGroup Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 ELITechGroup Recent Developments/Updates
6.13.6 ELITechGroup Competitive Strengths & Weaknesses
6.14 Vela Diagnostics
6.14.1 Vela Diagnostics Details
6.14.2 Vela Diagnostics Major Business
6.14.3 Vela Diagnostics Hematology Oncology Diagnostics Product and Services
6.14.4 Vela Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Vela Diagnostics Recent Developments/Updates
6.14.6 Vela Diagnostics Competitive Strengths & Weaknesses
6.15 Gentronix
6.15.1 Gentronix Details
6.15.2 Gentronix Major Business
6.15.3 Gentronix Hematology Oncology Diagnostics Product and Services
6.15.4 Gentronix Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Gentronix Recent Developments/Updates
6.15.6 Gentronix Competitive Strengths & Weaknesses
6.16 BioIVT
6.16.1 BioIVT Details
6.16.2 BioIVT Major Business
6.16.3 BioIVT Hematology Oncology Diagnostics Product and Services
6.16.4 BioIVT Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 BioIVT Recent Developments/Updates
6.16.6 BioIVT Competitive Strengths & Weaknesses
6.17 SAGA Diagnostics
6.17.1 SAGA Diagnostics Details
6.17.2 SAGA Diagnostics Major Business
6.17.3 SAGA Diagnostics Hematology Oncology Diagnostics Product and Services
6.17.4 SAGA Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 SAGA Diagnostics Recent Developments/Updates
6.17.6 SAGA Diagnostics Competitive Strengths & Weaknesses
6.18 Berry Genomics
6.18.1 Berry Genomics Details
6.18.2 Berry Genomics Major Business
6.18.3 Berry Genomics Hematology Oncology Diagnostics Product and Services
6.18.4 Berry Genomics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Berry Genomics Recent Developments/Updates
6.18.6 Berry Genomics Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Hematology Oncology Diagnostics and Key Manufacturers
7.2 Hematology Oncology Diagnostics Manufacturing Costs
7.3 Hematology Oncology Diagnostics Production Process
7.4 Hematology Oncology Diagnostics Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Hematology Oncology Diagnostics Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Hematology Oncology Diagnostics Typical Distributors
8.3 Hematology Oncology Diagnostics Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Hematology Oncology Diagnostics Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Hematology Oncology Diagnostics Market Size by Region (2017-2022) & (USD Million)
Table 3. World Hematology Oncology Diagnostics Market Size by Region (2023-2028) & (USD Million)
Table 4. World Hematology Oncology Diagnostics Market Size Market Share by Region (2017-2022)
Table 5. World Hematology Oncology Diagnostics Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Hematology Oncology Diagnostics Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Hematology Oncology Diagnostics Players in 2021
Table 9. World Hematology Oncology Diagnostics Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Hematology Oncology Diagnostics Company Evaluation Quadrant
Table 11. Head Office of Key Hematology Oncology Diagnostics Player
Table 12. Hematology Oncology Diagnostics Market: Company Product Type Footprint
Table 13. Hematology Oncology Diagnostics Market: Company Product Application Footprint
Table 14. Hematology Oncology Diagnostics Mergers & Acquisitions Activity
Table 15. United States VS China Hematology Oncology Diagnostics Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Hematology Oncology Diagnostics in United States, Headquarters (States, Country)
Table 17. United States Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Hematology Oncology Diagnostics Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Hematology Oncology Diagnostics in China, Company Headquarters (Province, Country)
Table 20. China Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Hematology Oncology Diagnostics Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Hematology Oncology Diagnostics in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Hematology Oncology Diagnostics Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Hematology Oncology Diagnostics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Hematology Oncology Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 27. World Hematology Oncology Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 28. World Hematology Oncology Diagnostics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Hematology Oncology Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 30. World Hematology Oncology Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Laboratories Basic Information, Area Served and Competitors
Table 32. Abbott Laboratories Major Business
Table 33. Abbott Laboratories Hematology Oncology Diagnostics Product and Services
Table 34. Abbott Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Laboratories Recent Developments/Updates
Table 36. Abbott Laboratories Competitive Strengths & Weaknesses
Table 37. Roche Basic Information, Area Served and Competitors
Table 38. Roche Major Business
Table 39. Roche Hematology Oncology Diagnostics Product and Services
Table 40. Roche Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Roche Recent Developments/Updates
Table 42. Roche Competitive Strengths & Weaknesses
Table 43. QIAGEN Basic Information, Area Served and Competitors
Table 44. QIAGEN Major Business
Table 45. QIAGEN Hematology Oncology Diagnostics Product and Services
Table 46. QIAGEN Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. QIAGEN Recent Developments/Updates
Table 48. QIAGEN Competitive Strengths & Weaknesses
Table 49. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 50. Thermo Fisher Scientific Major Business
Table 51. Thermo Fisher Scientific Hematology Oncology Diagnostics Product and Services
Table 52. Thermo Fisher Scientific Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Thermo Fisher Scientific Recent Developments/Updates
Table 54. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 55. Illumina Basic Information, Area Served and Competitors
Table 56. Illumina Major Business
Table 57. Illumina Hematology Oncology Diagnostics Product and Services
Table 58. Illumina Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Illumina Recent Developments/Updates
Table 60. Illumina Competitive Strengths & Weaknesses
Table 61. Bio-Rad Basic Information, Area Served and Competitors
Table 62. Bio-Rad Major Business
Table 63. Bio-Rad Hematology Oncology Diagnostics Product and Services
Table 64. Bio-Rad Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Bio-Rad Recent Developments/Updates
Table 66. Bio-Rad Competitive Strengths & Weaknesses
Table 67. ArcherDX Basic Information, Area Served and Competitors
Table 68. ArcherDX Major Business
Table 69. ArcherDX Hematology Oncology Diagnostics Product and Services
Table 70. ArcherDX Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. ArcherDX Recent Developments/Updates
Table 72. ArcherDX Competitive Strengths & Weaknesses
Table 73. ARUP Laboratories Basic Information, Area Served and Competitors
Table 74. ARUP Laboratories Major Business
Table 75. ARUP Laboratories Hematology Oncology Diagnostics Product and Services
Table 76. ARUP Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. ARUP Laboratories Recent Developments/Updates
Table 78. ARUP Laboratories Competitive Strengths & Weaknesses
Table 79. Asuragen Basic Information, Area Served and Competitors
Table 80. Asuragen Major Business
Table 81. Asuragen Hematology Oncology Diagnostics Product and Services
Table 82. Asuragen Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Asuragen Recent Developments/Updates
Table 84. Asuragen Competitive Strengths & Weaknesses
Table 85. Invivoscribe Basic Information, Area Served and Competitors
Table 86. Invivoscribe Major Business
Table 87. Invivoscribe Hematology Oncology Diagnostics Product and Services
Table 88. Invivoscribe Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Invivoscribe Recent Developments/Updates
Table 90. Invivoscribe Competitive Strengths & Weaknesses
Table 91. Adaptive Biotechnologies Basic Information, Area Served and Competitors
Table 92. Adaptive Biotechnologies Major Business
Table 93. Adaptive Biotechnologies Hematology Oncology Diagnostics Product and Services
Table 94. Adaptive Biotechnologies Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Adaptive Biotechnologies Recent Developments/Updates
Table 96. Adaptive Biotechnologies Competitive Strengths & Weaknesses
Table 97. Amoy Diagnostics Basic Information, Area Served and Competitors
Table 98. Amoy Diagnostics Major Business
Table 99. Amoy Diagnostics Hematology Oncology Diagnostics Product and Services
Table 100. Amoy Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Amoy Diagnostics Recent Developments/Updates
Table 102. Amoy Diagnostics Competitive Strengths & Weaknesses
Table 103. ELITechGroup Basic Information, Area Served and Competitors
Table 104. ELITechGroup Major Business
Table 105. ELITechGroup Hematology Oncology Diagnostics Product and Services
Table 106. ELITechGroup Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. ELITechGroup Recent Developments/Updates
Table 108. ELITechGroup Competitive Strengths & Weaknesses
Table 109. Vela Diagnostics Basic Information, Area Served and Competitors
Table 110. Vela Diagnostics Major Business
Table 111. Vela Diagnostics Hematology Oncology Diagnostics Product and Services
Table 112. Vela Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Vela Diagnostics Recent Developments/Updates
Table 114. Vela Diagnostics Competitive Strengths & Weaknesses
Table 115. Gentronix Basic Information, Area Served and Competitors
Table 116. Gentronix Major Business
Table 117. Gentronix Hematology Oncology Diagnostics Product and Services
Table 118. Gentronix Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Gentronix Recent Developments/Updates
Table 120. Gentronix Competitive Strengths & Weaknesses
Table 121. BioIVT Basic Information, Area Served and Competitors
Table 122. BioIVT Major Business
Table 123. BioIVT Hematology Oncology Diagnostics Product and Services
Table 124. BioIVT Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. BioIVT Recent Developments/Updates
Table 126. BioIVT Competitive Strengths & Weaknesses
Table 127. SAGA Diagnostics Basic Information, Area Served and Competitors
Table 128. SAGA Diagnostics Major Business
Table 129. SAGA Diagnostics Hematology Oncology Diagnostics Product and Services
Table 130. SAGA Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. SAGA Diagnostics Recent Developments/Updates
Table 132. Berry Genomics Basic Information, Area Served and Competitors
Table 133. Berry Genomics Major Business
Table 134. Berry Genomics Hematology Oncology Diagnostics Product and Services
Table 135. Berry Genomics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 136. Hematology Oncology Diagnostics Raw Material
Table 137. Key Manufacturers of Hematology Oncology Diagnostics Raw Materials
Table 138. Hematology Oncology Diagnostics Typical Distributors
Table 139. Hematology Oncology Diagnostics Typical Customers
Table 1. World Hematology Oncology Diagnostics Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Hematology Oncology Diagnostics Market Size by Region (2017-2022) & (USD Million)
Table 3. World Hematology Oncology Diagnostics Market Size by Region (2023-2028) & (USD Million)
Table 4. World Hematology Oncology Diagnostics Market Size Market Share by Region (2017-2022)
Table 5. World Hematology Oncology Diagnostics Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Hematology Oncology Diagnostics Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Hematology Oncology Diagnostics Players in 2021
Table 9. World Hematology Oncology Diagnostics Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Hematology Oncology Diagnostics Company Evaluation Quadrant
Table 11. Head Office of Key Hematology Oncology Diagnostics Player
Table 12. Hematology Oncology Diagnostics Market: Company Product Type Footprint
Table 13. Hematology Oncology Diagnostics Market: Company Product Application Footprint
Table 14. Hematology Oncology Diagnostics Mergers & Acquisitions Activity
Table 15. United States VS China Hematology Oncology Diagnostics Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Hematology Oncology Diagnostics in United States, Headquarters (States, Country)
Table 17. United States Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Hematology Oncology Diagnostics Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Hematology Oncology Diagnostics in China, Company Headquarters (Province, Country)
Table 20. China Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Hematology Oncology Diagnostics Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Hematology Oncology Diagnostics in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Hematology Oncology Diagnostics Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Hematology Oncology Diagnostics Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Hematology Oncology Diagnostics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Hematology Oncology Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 27. World Hematology Oncology Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 28. World Hematology Oncology Diagnostics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Hematology Oncology Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 30. World Hematology Oncology Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Laboratories Basic Information, Area Served and Competitors
Table 32. Abbott Laboratories Major Business
Table 33. Abbott Laboratories Hematology Oncology Diagnostics Product and Services
Table 34. Abbott Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Laboratories Recent Developments/Updates
Table 36. Abbott Laboratories Competitive Strengths & Weaknesses
Table 37. Roche Basic Information, Area Served and Competitors
Table 38. Roche Major Business
Table 39. Roche Hematology Oncology Diagnostics Product and Services
Table 40. Roche Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Roche Recent Developments/Updates
Table 42. Roche Competitive Strengths & Weaknesses
Table 43. QIAGEN Basic Information, Area Served and Competitors
Table 44. QIAGEN Major Business
Table 45. QIAGEN Hematology Oncology Diagnostics Product and Services
Table 46. QIAGEN Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. QIAGEN Recent Developments/Updates
Table 48. QIAGEN Competitive Strengths & Weaknesses
Table 49. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 50. Thermo Fisher Scientific Major Business
Table 51. Thermo Fisher Scientific Hematology Oncology Diagnostics Product and Services
Table 52. Thermo Fisher Scientific Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Thermo Fisher Scientific Recent Developments/Updates
Table 54. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 55. Illumina Basic Information, Area Served and Competitors
Table 56. Illumina Major Business
Table 57. Illumina Hematology Oncology Diagnostics Product and Services
Table 58. Illumina Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Illumina Recent Developments/Updates
Table 60. Illumina Competitive Strengths & Weaknesses
Table 61. Bio-Rad Basic Information, Area Served and Competitors
Table 62. Bio-Rad Major Business
Table 63. Bio-Rad Hematology Oncology Diagnostics Product and Services
Table 64. Bio-Rad Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Bio-Rad Recent Developments/Updates
Table 66. Bio-Rad Competitive Strengths & Weaknesses
Table 67. ArcherDX Basic Information, Area Served and Competitors
Table 68. ArcherDX Major Business
Table 69. ArcherDX Hematology Oncology Diagnostics Product and Services
Table 70. ArcherDX Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. ArcherDX Recent Developments/Updates
Table 72. ArcherDX Competitive Strengths & Weaknesses
Table 73. ARUP Laboratories Basic Information, Area Served and Competitors
Table 74. ARUP Laboratories Major Business
Table 75. ARUP Laboratories Hematology Oncology Diagnostics Product and Services
Table 76. ARUP Laboratories Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. ARUP Laboratories Recent Developments/Updates
Table 78. ARUP Laboratories Competitive Strengths & Weaknesses
Table 79. Asuragen Basic Information, Area Served and Competitors
Table 80. Asuragen Major Business
Table 81. Asuragen Hematology Oncology Diagnostics Product and Services
Table 82. Asuragen Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Asuragen Recent Developments/Updates
Table 84. Asuragen Competitive Strengths & Weaknesses
Table 85. Invivoscribe Basic Information, Area Served and Competitors
Table 86. Invivoscribe Major Business
Table 87. Invivoscribe Hematology Oncology Diagnostics Product and Services
Table 88. Invivoscribe Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Invivoscribe Recent Developments/Updates
Table 90. Invivoscribe Competitive Strengths & Weaknesses
Table 91. Adaptive Biotechnologies Basic Information, Area Served and Competitors
Table 92. Adaptive Biotechnologies Major Business
Table 93. Adaptive Biotechnologies Hematology Oncology Diagnostics Product and Services
Table 94. Adaptive Biotechnologies Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Adaptive Biotechnologies Recent Developments/Updates
Table 96. Adaptive Biotechnologies Competitive Strengths & Weaknesses
Table 97. Amoy Diagnostics Basic Information, Area Served and Competitors
Table 98. Amoy Diagnostics Major Business
Table 99. Amoy Diagnostics Hematology Oncology Diagnostics Product and Services
Table 100. Amoy Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Amoy Diagnostics Recent Developments/Updates
Table 102. Amoy Diagnostics Competitive Strengths & Weaknesses
Table 103. ELITechGroup Basic Information, Area Served and Competitors
Table 104. ELITechGroup Major Business
Table 105. ELITechGroup Hematology Oncology Diagnostics Product and Services
Table 106. ELITechGroup Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. ELITechGroup Recent Developments/Updates
Table 108. ELITechGroup Competitive Strengths & Weaknesses
Table 109. Vela Diagnostics Basic Information, Area Served and Competitors
Table 110. Vela Diagnostics Major Business
Table 111. Vela Diagnostics Hematology Oncology Diagnostics Product and Services
Table 112. Vela Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Vela Diagnostics Recent Developments/Updates
Table 114. Vela Diagnostics Competitive Strengths & Weaknesses
Table 115. Gentronix Basic Information, Area Served and Competitors
Table 116. Gentronix Major Business
Table 117. Gentronix Hematology Oncology Diagnostics Product and Services
Table 118. Gentronix Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Gentronix Recent Developments/Updates
Table 120. Gentronix Competitive Strengths & Weaknesses
Table 121. BioIVT Basic Information, Area Served and Competitors
Table 122. BioIVT Major Business
Table 123. BioIVT Hematology Oncology Diagnostics Product and Services
Table 124. BioIVT Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. BioIVT Recent Developments/Updates
Table 126. BioIVT Competitive Strengths & Weaknesses
Table 127. SAGA Diagnostics Basic Information, Area Served and Competitors
Table 128. SAGA Diagnostics Major Business
Table 129. SAGA Diagnostics Hematology Oncology Diagnostics Product and Services
Table 130. SAGA Diagnostics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. SAGA Diagnostics Recent Developments/Updates
Table 132. Berry Genomics Basic Information, Area Served and Competitors
Table 133. Berry Genomics Major Business
Table 134. Berry Genomics Hematology Oncology Diagnostics Product and Services
Table 135. Berry Genomics Hematology Oncology Diagnostics Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 136. Hematology Oncology Diagnostics Raw Material
Table 137. Key Manufacturers of Hematology Oncology Diagnostics Raw Materials
Table 138. Hematology Oncology Diagnostics Typical Distributors
Table 139. Hematology Oncology Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Hematology Oncology Diagnostics Picture
Figure 2. World Hematology Oncology Diagnostics Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Hematology Oncology Diagnostics Total Market Size (2017-2028) & (USD Million)
Figure 4. World Hematology Oncology Diagnostics Market Size Market Share by Region (2017-2028)
Figure 5. United States Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 6. China Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 7. Europe Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 8. Japan Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 11. India Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 12. Hematology Oncology Diagnostics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Hematology Oncology Diagnostics by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Hematology Oncology Diagnostics Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Hematology Oncology Diagnostics Markets in 2021
Figure 17. United States VS China: Hematology Oncology Diagnostics Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Hematology Oncology Diagnostics Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Hematology Oncology Diagnostics Market Size Market Share by Type in 2021
Figure 20. PCR
Figure 21. IHC
Figure 22. NGS
Figure 23. Cytogenetics
Figure 24. Others
Figure 25. World Hematology Oncology Diagnostics Market Size Market Share by Type (2017-2028)
Figure 26. World Hematology Oncology Diagnostics Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Hematology Oncology Diagnostics Market Size Market Share by Application in 2021
Figure 28. Clinical Laboratories
Figure 29. Hospitals
Figure 30. Research Institutes
Figure 31. Other
Figure 32. World Hematology Oncology Diagnostics Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Hematology Oncology Diagnostics in 2021
Figure 34. Manufacturing Process Analysis of Hematology Oncology Diagnostics
Figure 35. Hematology Oncology Diagnostics Industrial Chain
Figure 36. Distribution Channel Breakdown for Hematology Oncology Diagnostics Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Hematology Oncology Diagnostics Picture
Figure 2. World Hematology Oncology Diagnostics Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Hematology Oncology Diagnostics Total Market Size (2017-2028) & (USD Million)
Figure 4. World Hematology Oncology Diagnostics Market Size Market Share by Region (2017-2028)
Figure 5. United States Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 6. China Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 7. Europe Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 8. Japan Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 11. India Hematology Oncology Diagnostics Market Size (2017-2028) & (USD Million)
Figure 12. Hematology Oncology Diagnostics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Hematology Oncology Diagnostics by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Hematology Oncology Diagnostics Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Hematology Oncology Diagnostics Markets in 2021
Figure 17. United States VS China: Hematology Oncology Diagnostics Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Hematology Oncology Diagnostics Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Hematology Oncology Diagnostics Market Size Market Share by Type in 2021
Figure 20. PCR
Figure 21. IHC
Figure 22. NGS
Figure 23. Cytogenetics
Figure 24. Others
Figure 25. World Hematology Oncology Diagnostics Market Size Market Share by Type (2017-2028)
Figure 26. World Hematology Oncology Diagnostics Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Hematology Oncology Diagnostics Market Size Market Share by Application in 2021
Figure 28. Clinical Laboratories
Figure 29. Hospitals
Figure 30. Research Institutes
Figure 31. Other
Figure 32. World Hematology Oncology Diagnostics Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Hematology Oncology Diagnostics in 2021
Figure 34. Manufacturing Process Analysis of Hematology Oncology Diagnostics
Figure 35. Hematology Oncology Diagnostics Industrial Chain
Figure 36. Distribution Channel Breakdown for Hematology Oncology Diagnostics Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
